Sickle cell disease and aortic valve replacement - Use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration
Sw. Sutton et al., Sickle cell disease and aortic valve replacement - Use of cardiopulmonary bypass, partial exchange transfusion, platelet sequestration, and continuous hemofiltration, TEX HEART I, 26(4), 1999, pp. 283-288
Sickle cell disease in patients undergoing open hear? procedures presents a
multitude of challenges to the medical staff With improved techniques of c
ardiopulmonary bypass, surgery, and anesthesia for treating patients with s
ickle cell disease, perfusionists will likely encounter patients with this
genetic disorder on a more frequent basis.
A 40-year-old black woman was admitted to our institution with recurrent St
aphylococcus epidermidis and sepsis. She underwent transesophageal echocard
iography and cardiac catheterization and was subsequently diagnosed with se
vere aortic insufficiency The aortic valve was replaced. Herein, we report
our experience in he preoperative, perioperative, and postoperative managem
ent of this patient. We present a concise update on the current literature
and techniques used by others in similar cases, and we provide a brief sect
ion on future considerations to assist fellow practitioners in recognizing
this dis ease and meeting the accompanying challenges.